OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - EDWARDS LIFESCIENCES | Market Closed - Boerse Frankfurt Warrants 20:47:02 21/05/2024 BST | ||
| 8.43 EUR | -0.71% |
|
| Current month | -7.14% | ||
| 1 month | -5.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 21/05/24 | 8.45 | -0.47% |
| 20/05/24 | 8.49 | -0.59% |
| 17/05/24 | 8.54 | +1.43% |
| 16/05/24 | 8.42 | -0.12% |
| 15/05/24 | 8.43 | -4.53% |
Real-time Boerse Frankfurt Warrants
Last update May 21, 2024 at 08:47 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SW7JN8 |
| ISIN | DE000SW7JN81 |
| Date issued | 11/03/2024 |
| Strike | 181.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 8.11 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.1 € |
|---|---|
| Lowest since issue | 7.88 € |
| Spread | 0.01 € |
| Spread % | 0.12% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.34
USD
Average target price
95.9
USD
Spread / Average Target
+6.16%
- Stock Market
- Certificates
- Certificat
